11 February 2026
A revolutionary cancer treatment developed in Wellington has put patients with only months to live into long-term remission, and could be ready for the public system by 2027. In a special series, Stuff senior reporter Nicholas Jones reports on how the breakthrough was achieved, and what hurdles remain.
- Part 1: The mouse, the poet, and the revolutionary treatment that stopped a deadly cancer
- Part 2: Their baby was 4 months old. Her husband was dying. New Zealand had no treatment
- Part 3: Why public access to a life-changing cancer treatment is ‘on a knife edge’
- Part 4: He spent decades backing an idea others dismissed. Now patients are alive because of it
- Part 5: He made a PowerPoint for his funeral. Then his cancer went into remission
Support bringing CAR T-cell therapy to Aotearoa New Zealand
Join us in making CAR T-cell therapy accessible and affordable for all New Zealanders in need.
To learn more about how you can join this ground-breaking effort please contact the Malaghan Institute's philanthropy specialist An-Li Theron.
Or, if you're keen to support our efforts in other ways, contact the Malaghan Institute's communications team.
Related articles
Celebrating milestones in bringing life-saving cell therapies to New Zealand
12 November 2025
Marsden funding to drive discovery and innovation in cancer, allergy and infectious disease research
5 November 2025
Developing next generation CAR T-cell therapies for more equitable cancer care
30 October 2025
Faster CARs: overcoming cellular exhaustion to enhance cancer immunotherapies
29 October 2025
Malaghan CAR T programme wins KiwiNet Research Commercialisation Award
23 October 2025
Study explores wearable devices to improve blood cancer patient monitoring
8 October 2025